DAVID DEFEO
Allopathic & Osteopathic Physicians|Internal Medicine|Critical Care Medicine WINSTON SALEM, NC NPI 1003851395
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Critical Care Medicine NC Acerta Pharma LLC All categories
General Payments — all program years on this page
$5,682.42
- Category: General Payments
- Program years: PY2018–2024
- Record count: 337
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,081.39 across 51 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,081.39 | 51 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $141.42 | 7 |
| United Therapeutics Corporation | $112.29 | 5 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $92.03 | 4 |
| Respicardia, Inc. | $85.40 | 1 |
| Regeneron Healthcare Solutions, Inc. | $78.03 | 4 |
| GlaxoSmithKline, LLC. | $63.45 | 4 |
| Relypsa, Inc. | $61.36 | 2 |
| Insmed, Inc. | $42.78 | 2 |
| Merck Sharp & Dohme Corporation | $41.86 | 3 |
| Gilead Sciences, Inc. | $38.79 | 2 |
| Mallinckrodt Hospital Products Inc. | $37.71 | 2 |
| Philips Electronics North America Corporation | $34.68 | 2 |
| GENZYME CORPORATION | $30.27 | 1 |
| Mylan Specialty L.P. | $29.00 | 1 |
| INOGEN, INC. | $25.13 | 2 |
| CSL Behring | $24.76 | 1 |
| Actelion Pharmaceuticals US, Inc. | $21.74 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.45 | 1 |
| Grifols USA, LLC | $19.39 | 1 |
| Avadel CNS Pharmaceuticals, LLC | $17.64 | 1 |
| Lilly USA, LLC | $16.93 | 1 |
| Amgen Inc. | $16.52 | 1 |
| PFIZER INC. | $16.12 | 1 |
| Electromed, Inc. | $14.64 | 1 |
By program year
Records — PY2024 (51)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.